PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 1999Archives of Neurology62 citations

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with relapsing-remitting multiple sclerosis (RRMS)

Design

Review

Authors

RRRichard A. Rudick

Discussion

Loading...

Member takes

Overview

This review highlights that disease-modifying drugs can significantly improve the clinical course of relapsing-remitting multiple sclerosis.

Structured PICO

P
Population
Patients with relapsing-remitting multiple sclerosis (RRMS)
I
Intervention
Disease-modifying drugs

This review highlights that disease-modifying drugs can significantly improve the clinical course of relapsing-remitting multiple sclerosis.

Cite This Study

Richard A. Rudick (1999) studied this question.

synapsesocial.com/papers/6a70d72f2fdcb5703edb69cehttps://doi.org/10.1001/archneur.56.9.1079
View Full Paper
Ask AI
Bookmark
Share